Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapyDouglas B. Johnson, Justin M. Balko, Violeta Sánchez et al.|Nature Communications|2016Cited by 572
Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responsesAmrendra Kumar, Anna E. Vilgelm|Journal for ImmunoTherapy of Cancer|2023Cited by 21
Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapyCarly Bess Scalise, Ann Richmond, Caroline A. Nebhan et al.|Breast Cancer Research and Treatment|2020Cited by 6